Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 25

Sort by

Sort Order Select

Journal Articles

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Darla K Liles, MD, Rodolfo Cançado, Julie Kanter, MD, Abdullah Kutlar, MD, Andreas Bruederle, Michael Shi, MD PhD, Federico Campigotto, Kenneth I. Ataga

Blood (2018) 132 (Supplement 1): 1082.

https://doi.org/10.1182/blood-2018-99-112201

Published: 2018

Journal Articles

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Blood (2017) 129 (17): 2429–2436.

https://doi.org/10.1182/blood-2016-09-742296

Published: 2017

Includes: Supplemental data

Journal Articles

Circulating Exosomal microRNAs Are Prognostic Markers in Multiple Myeloma

Salomon Manier, MD, Herve Avet-Loiseau, Federico Campigotto, MS, Karma Salem, MD, Daisy Huynh, BS, MS, Siobhan Glavey, MD, Antonio Sacco, BS, Aldo M Roccaro, MD PhD, Stephane Minvielle, Philippe Moreau, MD PhD, Thierry Facon, Xavier Leleu, MD PhD, Edie A. Weller, PhD, Irene M. Ghobrial, MD

Blood (2015) 126 (23): 1770.

https://doi.org/10.1182/blood.V126.23.1770.1770

Published: 2015

Journal Articles

Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)

Lakshmanan Krishnamurti, MD, Keith M. Sullivan, MD, Naynesh R. Kamani, MD, Edmund K Waller, MD PhD, Allistair Abraham, MD, Federico Campigotto, MS, Wandi Zhang, MD, Shannon Smith, MSN, Kathryn L. Hassell, MD, Laura Decastro, MD, Catherine J Wu, MD, Donna S. Neuberg, Sc.D., Mark C. Walters, MD

Blood (2015) 126 (23): 543.

https://doi.org/10.1182/blood.V126.23.543.543

Published: 2015

Journal Articles

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study

Jessica Donato, Federico Campigotto, Erik J. Uhlmann, Erika Coletti, Donna Neuberg, Griffin M. Weber, Jeffrey I. Zwicker

Blood (2015) 126 (4): 494–499.

https://doi.org/10.1182/blood-2015-02-626788

Published: 2015

Journal Articles

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea

Maureen M. Okam, Erica B. Esrick, Elyse Mandell, Federico Campigotto, Donna S. Neuberg, Benjamin L. Ebert

Blood (2015) 125 (23): 3668–3669.

https://doi.org/10.1182/blood-2015-03-635391

Published: 2015

Journal Articles

Marked hyperferritinemia does not predict for HLH in the adult population

Alison M. Schram, Federico Campigotto, Ann Mullally, Annemarie Fogerty, Elena Massarotti, Donna Neuberg, Nancy Berliner

Blood (2015) 125 (10): 1548–1552.

https://doi.org/10.1182/blood-2014-10-602607

Published: 2015

Journal Articles

Prognostic Value of Circulating Exosomal microRNAs in 112 Patients with Multiple Myeloma

Salomon Manier, MD, Herve Avet-Loiseau, Federico Campigotto, MS, Siobhan Glavey, MD, Karma Salem, MD, Daisy Huynh, MPS, Erica N Boswell, BS, Antonio Sacco, BS, Yuji Mishima, PhD, Michele Moschetta, MD, Michaela R. Reagan, PhD, Yawara Kawano, MDPhD, Kenneth C. Anderson, MD, Aldo M Roccaro, MD PhD, Philippe Moreau, MD, Thierry Facon, MD, Xavier Leleu, MD PhD, Edie A. Weller, PhD, Irene M. Ghobrial, MD

Blood (2014) 124 (21): 2056.

https://doi.org/10.1182/blood.V124.21.2056.2056

Published: 2014

Journal Articles

Marked Hyperferritinemia Does Not Predict for Hemophagocytic Lymphohistiocytosis (HLH) in the Adult Population

Alison M Schram, MD, Ann Mullally, MD, Federico Campigotto, MS, Annemarie E Fogerty, MD, Elena Massarotti, MD, Donna S. Neuberg, ScD, Nancy Berliner, MD

Blood (2014) 124 (21): 4951.

https://doi.org/10.1182/blood.V124.21.4951.4951

Published: 2014

Journal Articles

The Effects of Hemophilia on Socialization

Aric Parnes, MD, Christine Mitchell, MSW, Wentz Rachel, Federico Campigotto, MS, Latoya Lashley, Cathee Brunswick, Donna Neuberg, ScD, Judith C Lin, MD

Blood (2014) 124 (21): 5968.

https://doi.org/10.1182/blood.V124.21.5968.5968

Published: 2014

Journal Articles

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Jessica Donato, MD, Federico Campigotto, MS, Erika Coletti, BSN, Donna Neuberg, ScD, Griffin Weber, MD PhD, Jeffrey I. Zwicker, MD

Blood (2014) 124 (21): 348.

https://doi.org/10.1182/blood.V124.21.348.348

Published: 2014

Journal Articles

Pharmacologic Thromboprophylaxis Is Frequently Prescribed In Hospitalized Cancer Patients At Academic Medical Centers: A Prospective, Cross-Sectional, Multi-Center Study

Adam A. Rojan, MD, Nadia Q. Rehman, MD, Renee E. Funches, MD, Federico Campigotto, MS, Jonathan Webster, MD, Gregory C. Connolly, MD, Anita Aggarwal, DO, PhD, Dalia Mobarek, MD, MSc, Donna S. Neuberg, ScD, Ted Wun, MD, Frederick Rickles, MD, FACP, Michael B. Streiff, MD, Alok A. Khorana, MD, Jeffrey I. Zwicker, MD

Blood (2013) 122 (21): 2374.

https://doi.org/10.1182/blood.V122.21.2374.2374

Published: 2013

Journal Articles

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Yosra Aljawai, MS, Serena McDiarmid, Joseph Cappuccio, Federico Campigotto, MS, Steven Peter Treon, MD, MA, PhD, Edie A. Weller, PhD, Brenda M. Birmann, ScD, Irene M Ghobrial, MD

Blood (2013) 122 (21): 1713.

https://doi.org/10.1182/blood.V122.21.1713.1713

Published: 2013

Journal Articles

Refractory Anemia With Excess Blasts In Transformation (Acute Myeloid Leukemia with 20-29% Blasts) in Older Adults is Less Aggressive Than Acute Myeloid Leukemia With ≥30% Blasts

Blood (2013) 122 (21): 1345.

https://doi.org/10.1182/blood.V122.21.1345.1345

Published: 2013

Journal Articles

Rosuvastatin Lowers Circulating Tissue Factor Antigen-Bearing Microparticles In Metastatic Breast Cancer: A Phase II, Multi-Dose, Randomized Trial (MicroSTAT Trial)

Jeffrey I. Zwicker, MD, Erica L. Mayer, MD, Federico Campigotto, MS, Julia Geddings, Herold Christina, M.D., Sheryl Bowley, Ph.D., Gerburg Wulf, MD, Gary Horowitz, MD, Donna S. Neuberg, ScD, Nigel Mackman, PhD, Bruce Furie, MD

Blood (2013) 122 (21): 579.

https://doi.org/10.1182/blood.V122.21.579.579

Published: 2013

Journal Articles

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Joshua J. Field, Gene Lin, Maureen M. Okam, Elaine Majerus, Jeffrey Keefer, Onyinye Onyekwere, Ainsley Ross, Federico Campigotto, Donna Neuberg, Joel Linden, David G. Nathan

Blood (2013) 121 (17): 3329–3334.

https://doi.org/10.1182/blood-2012-11-465963

Published: 2013

Includes: Supplemental data

Journal Articles

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

Irene M. Ghobrial, Federico Campigotto, Timothy J. Murphy, Erica N. Boswell, Ranjit Banwait, Feda Azab, Stacey Chuma, Janet Kunsman, Amanda Donovan, Farzana Masood, Diane Warren, Scott Rodig, Kenneth C. Anderson, Paul G. Richardson, Edie Weller, Jeffrey Matous

Blood (2013) 121 (8): 1296–1303.

https://doi.org/10.1182/blood-2012-06-439307

Published: 2013

Journal Articles

Trends in All-Cause Mortality Among Older Patients with CML: A SEER Database Analysis

Andrew M. Brunner, MD, Federico Campigotto, MS, Benjamin J. Drapkin, MD, Hossein Sadrzadeh, MD, Donna S. Neuberg, ScD, Amir T Fathi, MD

Blood (2012) 120 (21): 3772.

https://doi.org/10.1182/blood.V120.21.3772.3772

Published: 2012

Journal Articles

Abnormalities in IgA and IgM are associated with treatment-resistant ITP

Jon E. Arnason, Federico Campigotto, Donna Neuberg, James B. Bussel

Blood (2012) 119 (21): 5016–5020.

https://doi.org/10.1182/blood-2011-09-381020

Published: 2012

Journal Articles

Final Results of the Phase II Trial of Single Agent Panobinostat (LBH589) in Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Irene M. Ghobrial, MD, Ranjit Banwait, MA, Tiffany Poon, BS, Federico Campigotto, MS, Erica N Boswell, BS, Stacey Chuma, BSN, Janet Kunsman, NP, Amanda Donovan, BS, Meghan Bagshaw, Diane Warren, Kenneth C. Anderson, MD, Paul G. Richardson, MD, Edie Weller, PhD, Timothy J. Murphy, MD, FACP, Jeffrey Matous, MD

Blood (2011) 118 (21): 2706.

https://doi.org/10.1182/blood.V118.21.2706.2706

Published: 2011

NARROW

Established Prevention of Vaso-Occlusive Crises with Crizanlizumab Is Further Improved in Patients Who Follow the Standard Treatment Regimen: Post-Hoc Analysis of the Phase II Sustain Study

Prognostic role of circulating exosomal miRNAs in multiple myeloma

Circulating Exosomal microRNAs Are Prognostic Markers in Multiple Myeloma

Results of a Multicenter Pilot Investigation of Bone Marrow Transplantation in Adults with Sickle Cell Disease (STRIDE)

Intracranial hemorrhage in patients with brain metastases treated with therapeutic enoxaparin: a matched cohort study

Phase 1/2 trial of vorinostat in patients with sickle cell disease who have not benefitted from hydroxyurea

Marked hyperferritinemia does not predict for HLH in the adult population

Prognostic Value of Circulating Exosomal microRNAs in 112 Patients with Multiple Myeloma

Marked Hyperferritinemia Does Not Predict for Hemophagocytic Lymphohistiocytosis (HLH) in the Adult Population

The Effects of Hemophilia on Socialization

Risk of Intracranial Hemorrhage Associated with Enoxaparin Administration in Patients with Brain Metastasis

Pharmacologic Thromboprophylaxis Is Frequently Prescribed In Hospitalized Cancer Patients At Academic Medical Centers: A Prospective, Cross-Sectional, Multi-Center Study

A Case-Control Epidemiological Study Of Waldenstrom Macroglobulinemia

Refractory Anemia With Excess Blasts In Transformation (Acute Myeloid Leukemia with 20-29% Blasts) in Older Adults is Less Aggressive Than Acute Myeloid Leukemia With ≥30% Blasts

Rosuvastatin Lowers Circulating Tissue Factor Antigen-Bearing Microparticles In Metastatic Breast Cancer: A Phase II, Multi-Dose, Randomized Trial (MicroSTAT Trial)

Sickle cell vaso-occlusion causes activation of iNKT cells that is decreased by the adenosine A 2A receptor agonist regadenoson

Results of a phase 2 trial of the single-agent histone deacetylase inhibitor panobinostat in patients with relapsed/refractory Waldenström macroglobulinemia

Trends in All-Cause Mortality Among Older Patients with CML: A SEER Database Analysis

Abnormalities in IgA and IgM are associated with treatment-resistant ITP

Final Results of the Phase II Trial of Single Agent Panobinostat (LBH589) in Relapsed or Relapsed/Refractory Waldenstrom Macroglobulinemia

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only